Skip to main content
logo
Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
6.14
-0.47 (-7.11%)
At close: Jul 13, 2026, 4:00 PM EDT
6.00
-0.14 (-2.28%)
After-hours: Jul 13, 2026, 7:00 PM EDT

Basel Medical Group Income Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
14.5511.3210.059.710.66
Revenue Growth (YoY)
45.57%12.63%3.60%-8.98%-
Cost of Revenue
12.678.955.895.586.21
Gross Profit
1.882.374.164.124.45
Selling, General & Admin
0.030.1400.020.01
Depreciation & Amortization Expenses
2.891.180.530.560.58
Other Operating Expenses
3.5613.651.511.581.71
Total Operating Expenses
6.4814.972.042.162.3
Operating Income
-4.6-12.62.121.962.15
Interest Expense
-0.32-0.2-0.18-0.24-0.32
Other Non-Operating Income (Expense)
4.871.750.460.410.55
Total Non-Operating Income (Expense)
4.551.550.280.170.23
Pretax Income
-10.4-11.052.42.132.39
Provision for Income Taxes
--0.420.33--
Net Income
-10.16-10.642.071.782.39
Minority Interest in Earnings
-0.11-0---
Net Income to Common
-10.05-10.642.071.782.39
Net Income Growth
--16.23%-25.27%-
Shares Outstanding (Basic)
192111
Shares Outstanding (Diluted)
192111
Shares Change (YoY)
113.42%15.60%---
EPS (Basic)
-6.81-6.841.561.321.44
EPS (Diluted)
-6.81-6.841.561.321.44
EPS Growth
--18.18%-8.33%-
Free Cash Flow
-2.56-4.62.52.592.7
Free Cash Flow Growth
---3.56%-4.07%-
Free Cash Flow Per Share
-0.14-2.941.851.922.00
Gross Margin
12.92%20.93%41.43%42.44%41.74%
Operating Margin
-31.59%-111.33%21.09%20.18%20.20%
Profit Margin
-69.81%-93.96%20.62%18.38%22.39%
FCF Margin
-17.58%-40.64%24.89%26.74%25.37%
EBITDA
-1.71-11.422.652.512.73
EBITDA Margin
-11.75%-100.89%26.35%25.92%25.61%
EBIT
-4.6-12.62.121.962.15
EBIT Margin
-31.59%-111.33%21.09%20.18%20.20%
Effective Tax Rate
-3.78%13.80%0.00%0.00%
SEC Filings: 10-K · 10-Q